Evidence-Based Practice Recommendations
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
The Institute for Clinical Systems Improvement recommends considering screening patients for substance use disorders when there is an unclear etiology of pain.
(https://www.icsi.org/wp-content/uploads/2019/10/Pain-Interactive-7th-V2-Ed-8.17.pdf Last Accessed: March 21, 2024)Level of Evidence: Expert Opinion/Consensus Statement
According to the World Health Organization, people likely to witness an opioid overdose should have access to naloxone and be instructed in its administration to enable them to use it for the emergency management of suspected opioid overdose.
(https://www.who.int/publications/i/item/9789241548816 Last Accessed: March 21, 2024)Strength of Recommendation/Level of Evidence: Strong/very low
When considering initiation of methadone, the American Pain Society recommends that clinicians perform an individualized medical and behavioral risk evaluation to assess risks and benefits of methadone, given methadone's specific pharmacologic properties and adverse effect profile.
(https://www.jpain.org/article/S1526-5900(14)00522-7/fulltext Last Accessed: March 21, 2024)Strength of Recommendation/Level of Evidence: Strong/low
For patients with opioid use disorder for whom opioid use disorder pharmacotherapy is contraindicated, unacceptable, or unavailable, the Department of Veterans Affairs Work Group has found there is insufficient evidence to recommend for or against any specific psychosocial interventions.
(https://www.healthquality.va.gov/guidelines/MH/sud/VADoDSUDCPG.pdf Last Accessed: March 21, 2024)Strength of Recommendation: Neither for not against
The World Health Organization recommends that healthcare providers should, at the earliest opportunity, advise pregnant women dependent on opioids to cease their use and offer, or refer to, detoxification services under medical supervision where necessary and applicable. Detoxification can be undertaken at any stage in pregnancy, but at no stage should antagonists (e.g., naloxone, naltrexone) be used to accelerate the detoxification process.
(https://www.who.int/publications/i/item/9789241548731 Last Accessed: March 21, 2024)Strength of Recommendation/Level of Evidence: Strong/very low
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.